Skip to main content
. 2015 May 5;5:101. doi: 10.3389/fonc.2015.00101

Figure 2.

Figure 2

(A) Survival by use of docetaxel chemotherapy: yes vs. no. (B) Survival by use of docetaxel with ADT refractory: yes vs. no.